FDA Brief

FDA warning letters

A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.

423 letters match. Newest first.

  1. Sabra Dipping Company, LLC

    FDA found Salmonella Havana in Sabra ready-to-eat hummus and cited preventive-control and sanitation failures at its Virginia plant.

    High risk
  2. Invacare Corporation

    FDA warned Invacare over quality-system failures in complaint handling and reporting for its oxygen concentrators.

    High risk
  3. Surgenex LLC

    FDA warned Surgenex it sold unapproved umbilical cord and amniotic membrane products for injection without a biologics license and with serious manufacturing problems.

    High risk
  4. Advanced Nutriceuticals, LLC dba The Guyer Institute of Molecular Medicine

    Advanced Nutriceuticals compounded sterile drugs without required prescriptions and under insanitary conditions, FDA says.

    High risk
  5. Joseph A. Zadra, M.D.

    FDA warned clinical investigator Dr. Zadra for enrolling an ineligible subject and skipping required safety labs in a drug study.

    High risk
  6. Owlet Baby Care, Inc.

    FDA warns Owlet Baby Care that its Smart Sock baby monitors are adulterated devices sold without marketing approval.

    High risk
  7. Lauren R. Klein, MD, M.S.

    FDA cited Dr. Lauren R. Klein for running two emergency department drug studies without required investigational new drug applications.

    High risk
  8. Jon B. Cole, MD

    FDA warns Dr. Jon B. Cole he ran two pre-hospital drug studies without required INDs, adding risks for pregnant women, children, and intoxicated patients.

    High risk
  9. RAAS Nutritionals, LLC/Rare Antibody Antigen Supply, Inc.

    FDA says RAAS Nutritionals ran human drug studies without required IND applications, despite claiming products were dietary supplements.

    High risk
  10. Laboratorio Pharma International SRL

    FDA warns Laboratorio Pharma International over CGMP failures, unapproved GELAZUL, misbranding, and incomplete beta-lactam separation.

    High risk
  11. Kaleido Biosciences, Inc.

    Kaleido Biosciences ran COVID-19 clinical trials of KB109 without required IND, FDA says.

    High risk
  12. Toyobo Co. Ltd.

    FDA warned Toyobo after inspection found unresolved particulate contamination and environmental monitoring data manipulation affecting sterile injectable drugs.

    High risk
  13. Utah Cord Bank LLC dba Utah Cell Bank

    Utah Cell Bank made unapproved injectable stem cell products and fell short on sterility and manufacturing controls, FDA found.

    High risk
  14. Midwestern Pet Food

    FDA warned Midwestern Pet Food over aflatoxin- and Salmonella-contaminated dog and cat food made under inadequate preventive controls.

    High risk
  15. Panjin Hetian Food Co., Ltd.

    FDA warns Panjin Hetian Food over serious food-safety violations in ready-to-eat rice protein powder, including missed Salmonella hazards and inadequate controls.

    High risk
  16. Market of Choice, LLC

    Market of Choice's Sour Cherry Baked Brie had undeclared almond, and its RTE salads lacked pathogen controls.

    High risk
  17. Utah Cord Bank LLC

    FDA cited Utah Cord Bank for unvalidated cord blood processing, missing environmental monitoring, procedures, and records after a February 2021 inspection.

    High risk
  18. Martinez Produce & Seafood Inc

    FDA: Chicago seafood processor and importer lacked a HACCP plan for vacuum-packed tuna and salmon and cleaned knives poorly.

    High risk
  19. Joe Wise Pharmacy, Inc., dba Wise Pharmacy

    FDA warned Wise Pharmacy that its compounded sterile and non-sterile drugs were adulterated by insanitary compounding conditions.

    High risk
  20. American Specialty Pharmacy, Inc. dba ASP Cares

    FDA warned outsourcing facility ASP Cares about sterile compounded drugs made under insanitary conditions and with CGMP violations.

    High risk
  21. Evelyn Lopez-Brignoni, M.D.

    FDA warns Dr. Evelyn Lopez-Brignoni over inadequate dosing in pediatric investigational drug trials.

    High risk
  22. Hawaii Health Systems Corporation dba Kona Community Hospital Pharmacy

    Kona Community Hospital Pharmacy prepared sterile drugs in insanitary conditions with microbial contamination and facility flaws.

    High risk
  23. buy-pharma.md

    FDA warned buy-pharma.md that its website sells unapproved prescription drugs, including azithromycin and hydroxychloroquine, with COVID-19 claims.

    High risk